Effects of GLP-1 receptor agonists on neurological complications of diabetes

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource, 1 online resource.
Language
Englisch

Bibliographic citation
Effects of GLP-1 receptor agonists on neurological complications of diabetes ; volume:24 ; number:4 ; day:26 ; month:5 ; year:2023 ; pages:655-672 ; date:8.2023
Reviews in endocrine & metabolic disorders ; 24, Heft 4 (26.5.2023), 655-672, 8.2023

Creator
García-Casares, Natalia
González-González, Guillermo
Cruz-Cosme, Carlos de la
Garzón-Maldonado, Francisco J.
Rojas-Leal, Carmen de
Ariza, María J.
Narváez, Manuel
Barbancho, Miguel Ángel
García-Arnés, Juan Antonio
Tinahones, Francisco J.
Contributor
SpringerLink (Online service)

DOI
10.1007/s11154-023-09807-3
URN
urn:nbn:de:101:1-2023110208052086625193
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • García-Casares, Natalia
  • González-González, Guillermo
  • Cruz-Cosme, Carlos de la
  • Garzón-Maldonado, Francisco J.
  • Rojas-Leal, Carmen de
  • Ariza, María J.
  • Narváez, Manuel
  • Barbancho, Miguel Ángel
  • García-Arnés, Juan Antonio
  • Tinahones, Francisco J.
  • SpringerLink (Online service)

Other Objects (12)

Nephroprotective effects of GLP-1 receptor agonists: where do we stand?

Nephroprotective effects of GLP-1 receptor agonists: where do we stand?

GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers

GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Potential implications of long-acting GLP-1 receptor agonists for critically ill

Potential implications of long-acting GLP-1 receptor agonists for critically ill

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?

Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?

GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition

GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?

Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study

Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study

GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off

GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off

Spatiotemporal GLP-1 and GIP Receptor Signaling and Trafficking/Recycling Dynamics Induced by Selected Receptor Mono- and Dual-agonists

Spatiotemporal GLP-1 and GIP Receptor Signaling and Trafficking/Recycling Dynamics Induced by Selected Receptor Mono- and Dual-agonists

Related objects